Chronic Kidney Disease (CKD) Drug Market Report

China Chronic Kidney Disease (CKD) Drug Industry Market Research Report 2023-2029

  • POSTDATE：Sep 15, 2023
  • PAGES：191
  • REPORT CODE：GMM1800165
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Chronic kidney disease (CKD) is a condition characterized by a gradual loss of renal function over time. To learn more about kidney function, see how your kidneys work. CKD is also known as chronic kidney disease.

    This report elaborates on the current development of the Chronic Kidney Disease (CKD) Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Raptor Pharmaceuticals

    • Xenetic Biosciences

    • FibroGen

    • ZS Pharma

    • Cara Therapeutics

    • Keryx Biopharmaceuticals

    • Shield Therapeutics

    • Reata Pharmaceuticals

    • AMAG Pharmaceuticals

    • OPKO Health

    • Abbott Laboratories

    • Takeda Pharmaceuticals

    • Actavis PLC

    • Johnson & Johnson

    • Amgen Inc

    • Sanofi

    • Regulus Therapeutics

    • Rockwell Medical

    • F Hoffmann-La Roche Ltd

    By Type:

    • Diuretics

    • Calcium channel blockers

    • Others

    • Erythropoiesis-stimulating agents (ESAs)

    • Angiotensin-II receptor blockers

    • Beta blockers

    • ACE Inhibitors

    By Application:

    • Specialty Clinics

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Chronic Kidney Disease (CKD) Drug Market Overview 2018-2029

    • 1.1 China Chronic Kidney Disease (CKD) Drug Industry Development Overview

    • 1.2 China Chronic Kidney Disease (CKD) Drug Industry Development History

    • 1.3 China Chronic Kidney Disease (CKD) Drug Industry Market Size (2018-2029)

    • 1.4 China Chronic Kidney Disease (CKD) Drug Market Analysis by Type from Production Side

      • 1.4.1 China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)

      • 1.4.2 China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Calcium channel blockers (2018-2029)

      • 1.4.3 China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Erythropoiesis-stimulating agents (ESAs) (2018-2029)

      • 1.4.5 China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Angiotensin-II receptor blockers (2018-2029)

      • 1.4.6 China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Beta blockers (2018-2029)

      • 1.4.7 China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of ACE Inhibitors (2018-2029)

    • 1.5 China Chronic Kidney Disease (CKD) Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Chronic Kidney Disease (CKD) Drug Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

      • 1.5.2 China Chronic Kidney Disease (CKD) Drug Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Chronic Kidney Disease (CKD) Drug Market Analysis by Region

      • 1.6.1 North China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Chronic Kidney Disease (CKD) Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Chronic Kidney Disease (CKD) Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Chronic Kidney Disease (CKD) Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Chronic Kidney Disease (CKD) Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Chronic Kidney Disease (CKD) Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Chronic Kidney Disease (CKD) Drug Industry Development

    Chapter 3 Chronic Kidney Disease (CKD) DrugIndustry Chain Analysis

    • 3.1 Chronic Kidney Disease (CKD) Drug Industry Chain

    • 3.2 Chronic Kidney Disease (CKD) Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Chronic Kidney Disease (CKD) Drug Market

    • 3.3 Chronic Kidney Disease (CKD) Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Chronic Kidney Disease (CKD) Drug Market

    Chapter 4 China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 4.1 China Chronic Kidney Disease (CKD) Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Chronic Kidney Disease (CKD) Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Diuretics

      • 4.5.2 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Calcium channel blockers

      • 4.5.3 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Others

      • 4.5.4 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Erythropoiesis-stimulating agents (ESAs)

      • 4.5.5 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Angiotensin-II receptor blockers

      • 4.5.6 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Beta blockers

      • 4.5.7 China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of ACE Inhibitors

    Chapter 5 China Chronic Kidney Disease (CKD) Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Chronic Kidney Disease (CKD) Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate of Specialty Clinics

      • 5.5.2 China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate of Hospitals

    Chapter 6 China Chronic Kidney Disease (CKD) Drug Market, by Region

    • 6.1 China Chronic Kidney Disease (CKD) Drug Production Volume and Production Value, by Region

    • 6.2 China Chronic Kidney Disease (CKD) Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Chronic Kidney Disease (CKD) Drug Market Analysis

    • 7.1 North China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 7.2 North China Chronic Kidney Disease (CKD) Drug Market, by Application

    Chapter 8 Central China Chronic Kidney Disease (CKD) Drug Market Analysis

    • 8.1 Central China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 8.2 Central China Chronic Kidney Disease (CKD) Drug Market, by Application

    Chapter 9 South China Chronic Kidney Disease (CKD) Drug Market Analysis

    • 9.1 South China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 9.2 South China Chronic Kidney Disease (CKD) Drug Market, by Application

    Chapter 10 East China Chronic Kidney Disease (CKD) Drug Market Analysis

    • 10.1 East China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 10.2 East China Chronic Kidney Disease (CKD) Drug Market, by Application

    Chapter 11 Northeast China Chronic Kidney Disease (CKD) Drug Market Analysis

    • 11.1 Northeast China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 11.2 Northeast China Chronic Kidney Disease (CKD) Drug Market, by Application

    Chapter 12 Southwest China Chronic Kidney Disease (CKD) Drug Market Analysis

    • 12.1 Southwest China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 12.2 Southwest China Chronic Kidney Disease (CKD) Drug Market, by Application

    Chapter 13 Northwest China Chronic Kidney Disease (CKD) Drug Market Analysis

    • 13.1 Northwest China Chronic Kidney Disease (CKD) Drug Market, by Type

    • 13.2 Northwest China Chronic Kidney Disease (CKD) Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Raptor Pharmaceuticals

        • 14.1.1 Raptor Pharmaceuticals Company Profile

        • 14.1.2 Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Xenetic Biosciences

        • 14.2.1 Xenetic Biosciences Company Profile

        • 14.2.2 Xenetic Biosciences Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 FibroGen

        • 14.3.1 FibroGen Company Profile

        • 14.3.2 FibroGen Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 ZS Pharma

        • 14.4.1 ZS Pharma Company Profile

        • 14.4.2 ZS Pharma Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Cara Therapeutics

        • 14.5.1 Cara Therapeutics Company Profile

        • 14.5.2 Cara Therapeutics Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Keryx Biopharmaceuticals

        • 14.6.1 Keryx Biopharmaceuticals Company Profile

        • 14.6.2 Keryx Biopharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Shield Therapeutics

        • 14.7.1 Shield Therapeutics Company Profile

        • 14.7.2 Shield Therapeutics Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Reata Pharmaceuticals

        • 14.8.1 Reata Pharmaceuticals Company Profile

        • 14.8.2 Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 AMAG Pharmaceuticals

        • 14.9.1 AMAG Pharmaceuticals Company Profile

        • 14.9.2 AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 OPKO Health

        • 14.10.1 OPKO Health Company Profile

        • 14.10.2 OPKO Health Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Abbott Laboratories

        • 14.11.1 Abbott Laboratories Company Profile

        • 14.11.2 Abbott Laboratories Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Takeda Pharmaceuticals

        • 14.12.1 Takeda Pharmaceuticals Company Profile

        • 14.12.2 Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Actavis PLC

        • 14.13.1 Actavis PLC Company Profile

        • 14.13.2 Actavis PLC Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Johnson & Johnson

        • 14.14.1 Johnson & Johnson Company Profile

        • 14.14.2 Johnson & Johnson Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Amgen Inc

        • 14.15.1 Amgen Inc Company Profile

        • 14.15.2 Amgen Inc Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Sanofi

        • 14.16.1 Sanofi Company Profile

        • 14.16.2 Sanofi Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Regulus Therapeutics

        • 14.17.1 Regulus Therapeutics Company Profile

        • 14.17.2 Regulus Therapeutics Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Rockwell Medical

        • 14.18.1 Rockwell Medical Company Profile

        • 14.18.2 Rockwell Medical Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 F Hoffmann-La Roche Ltd

        • 14.19.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.19.2 F Hoffmann-La Roche Ltd Chronic Kidney Disease (CKD) Drug Market Performance

        • 14.19.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Chronic Kidney Disease (CKD) Drug Industry Research Conclusions

    • 15.2 Chronic Kidney Disease (CKD) Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Chronic Kidney Disease (CKD) Drug Industry Market Size (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Diuretics (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Calcium channel blockers (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Erythropoiesis-stimulating agents (ESAs) (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Angiotensin-II receptor blockers (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of Beta blockers (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume, Production Value and Growth Rate of ACE Inhibitors (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)

    • Figure China Chronic Kidney Disease (CKD) Drug Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate from 2018-2029

    • Figure Chronic Kidney Disease (CKD) Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Chronic Kidney Disease (CKD) Drug Market Share by Type in 2018

    • Figure China Chronic Kidney Disease (CKD) Drug Market Share by Type in 2023

    • Figure China Chronic Kidney Disease (CKD) Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Diuretics (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Calcium channel blockers (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Erythropoiesis-stimulating agents (ESAs) (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Angiotensin-II receptor blockers (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of Beta blockers (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume and Growth Rate of ACE Inhibitors (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Market Share by Application in 2018

    • Figure China Chronic Kidney Disease (CKD) Drug Market Share by Application in 2023

    • Figure China Chronic Kidney Disease (CKD) Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate of Specialty Clinics (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Production Volume by Region (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Production Volume Share by Region (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Volume Share by Region (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Production Value by Region (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Production Value Share by Region (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Production Value Share by Region (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Sales Volume by Region (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Region (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Region (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Sales Value by Region (2018-2023)

    • Table China Chronic Kidney Disease (CKD) Drug Sales Value Share by Region (2018-2023)

    • Figure China Chronic Kidney Disease (CKD) Drug Sales Value Share by Region (2018-2023)

    • Table North China Chronic Kidney Disease (CKD) Drug Production Volume by Type (2018-2023)

    • Table North China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Figure North China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Table North China Chronic Kidney Disease (CKD) Drug Sales Volume by Application (2018-2023)

    • Table North China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Chronic Kidney Disease (CKD) Drug Production Volume by Type (2018-2023)

    • Table Central China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Table Central China Chronic Kidney Disease (CKD) Drug Sales Volume by Application (2018-2023)

    • Table Central China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Table South China Chronic Kidney Disease (CKD) Drug Production Volume by Type (2018-2023)

    • Table South China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Figure South China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Table South China Chronic Kidney Disease (CKD) Drug Sales Volume by Application (2018-2023)

    • Table South China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Table East China Chronic Kidney Disease (CKD) Drug Production Volume by Type (2018-2023)

    • Table East China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Figure East China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Table East China Chronic Kidney Disease (CKD) Drug Sales Volume by Application (2018-2023)

    • Table East China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Chronic Kidney Disease (CKD) Drug Production Volume by Type (2018-2023)

    • Table Northeast China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Chronic Kidney Disease (CKD) Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Chronic Kidney Disease (CKD) Drug Production Volume by Type (2018-2023)

    • Table Southwest China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Chronic Kidney Disease (CKD) Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Chronic Kidney Disease (CKD) Drug Production Volume by Type (2018-2023)

    • Table Northwest China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Chronic Kidney Disease (CKD) Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Chronic Kidney Disease (CKD) Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Chronic Kidney Disease (CKD) Drug Sales Volume Share by Application (2018-2023)

    • Table Raptor Pharmaceuticals Company Profile

    • Table Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Xenetic Biosciences Company Profile

    • Table Xenetic Biosciences Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table FibroGen Company Profile

    • Table FibroGen Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table ZS Pharma Company Profile

    • Table ZS Pharma Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Cara Therapeutics Company Profile

    • Table Cara Therapeutics Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Keryx Biopharmaceuticals Company Profile

    • Table Keryx Biopharmaceuticals Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Shield Therapeutics Company Profile

    • Table Shield Therapeutics Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Reata Pharmaceuticals Company Profile

    • Table Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table AMAG Pharmaceuticals Company Profile

    • Table AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table OPKO Health Company Profile

    • Table OPKO Health Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Takeda Pharmaceuticals Company Profile

    • Table Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Actavis PLC Company Profile

    • Table Actavis PLC Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Amgen Inc Company Profile

    • Table Amgen Inc Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Regulus Therapeutics Company Profile

    • Table Regulus Therapeutics Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table Rockwell Medical Company Profile

    • Table Rockwell Medical Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Chronic Kidney Disease (CKD) Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US